BREAKING: Johnson & Johnson to break into two, separating retail products business from prescription drugs and medical devices.
FILE - This Oct. 16, 2012 file photo shows the Johnson & Johnson logo on a package of Band-Aids, in St. Petersburg, Fla. Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine, from its medical device and prescription drug business. The company selling prescription drugs and medical devices will keep Johnson & Johnson as its name, the company said Friday, Nov. 12, 2021.
The company said Friday the move will help improve the focus and speed of each company to address trends in their different industries. The new consumer health company will house brands including Neutrogena, Aveeno, Tylenol, Listerine, Johnson’s, and Band-Aid. It is expected to generate revenue of approximately $15 billion for the year. A name was not disclosed for the new company.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Jade Thirlwall denies Little Mix split rumours and wants 20 more years with bandLittle Mix singer Jade Thirlwall has quashed rumours of the band splitting up and says she wants the girls to stay together for another 20 years so they can celebrate their 30th anniversary
Weiterlesen »
Lucy Dacus Amps Up Her Dark Murder Fantasy With a Full-Band Version of 'Thumbs'Lucy Dacus has released a full-band version of 'Thumbs,' her immensely dark and devastating track off 'Home Video.'
Weiterlesen »
WSJ News Exclusive | Johnson & Johnson Plans to Split Into Two Public CompaniesJohnson & Johnson intends to separate its high-margin but risky prescription-drugs and medical-devices business from its storied but slower-growing consumer group, creating two publicly traded companies.
Weiterlesen »
Judge to rule on request to halt Johnson & Johnson talc lawsuitsA U.S. judge is expected to announce on Wednesday whether Johnson & Johnson must continue defending against tens of thousands of claims that its baby powder and other talc-containing products caused mesothelioma and ovarian cancer.
Weiterlesen »
EU lists rare spinal condition as side-effect of J&J COVID-19 shotEurope's drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of Johnson & Johnson's single-dose COVID-19 vaccine.
Weiterlesen »